362 related articles for article (PubMed ID: 34320270)
1. Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population.
Choden S; Wangmo C; Maharjan S
Diagn Cytopathol; 2021 Nov; 49(11):1179-1187. PubMed ID: 34320270
[TBL] [Abstract][Full Text] [Related]
2. Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
Higuchi M; Hirokawa M; Kanematsu R; Tanaka A; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
Endocr J; 2018 Dec; 65(12):1193-1198. PubMed ID: 30282887
[TBL] [Abstract][Full Text] [Related]
3. Bethesda System Categories of Fine Needle Aspiration Cytology Are Not Associated with Thyroid Nodule Location: A Single Institution Experience.
Xavier-Júnior JCC; Abrantkoski Borges F; Pizzello Zogheib RJ; Camilo-Júnior DJ
Acta Cytol; 2021; 65(1):22-26. PubMed ID: 32877898
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
Zhou H; Baloch ZW; Nayar R; Bizzarro T; Fadda G; Adhikari-Guragain D; Hatem J; Larocca LM; Samolczyk J; Slade J; Rossi ED
Cancer Cytopathol; 2018 Jan; 126(1):20-26. PubMed ID: 28941185
[TBL] [Abstract][Full Text] [Related]
5. Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology?
Kopczyński J; Suligowska A; Niemyska K; Pałyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
Endocr Pathol; 2020 Jun; 31(2):143-149. PubMed ID: 32236858
[TBL] [Abstract][Full Text] [Related]
6. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Pediatric Population.
Vuong HG; Suzuki A; Na HY; Tuyen PV; Khuy DM; Nguyen HC; Jitpasutham T; Abelardo A; Amano T; Park SY; Jung CK; Hirokawa M; Katoh R; Kakudo K; Bychkov A
Am J Clin Pathol; 2021 Apr; 155(5):680-689. PubMed ID: 33269383
[TBL] [Abstract][Full Text] [Related]
7. A Large Thyroid Fine Needle Aspiration Biopsy Cohort with Long-Term Population-Based Follow-Up.
Ng DL; van Zante A; Griffin A; Hills NK; Ljung BM
Thyroid; 2021 Jul; 31(7):1086-1095. PubMed ID: 33371796
[No Abstract] [Full Text] [Related]
8. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
9. Impact of the 3rd Edition of the Bethesda System for Reporting Thyroid Cytopathology on Grey Zone Categories.
Guerreiro SC; Tastekin E; Mourao M; Loureiro I; Eusebio R; Marques HP; Oznur M; Caliskan CK; Schmitt FC; Bongiovanni M; Canberk S
Acta Cytol; 2023; 67(6):593-603. PubMed ID: 37899024
[TBL] [Abstract][Full Text] [Related]
10. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
11. The Bethesda System for Reporting Thyroid Cytopathology: A Retrospective Review of its Diagnostic Utility at Johns Hopkins Aramco Healthcare, Saudi Arabia.
Alhashem MH; Alabidi A; Aly MG
Am J Otolaryngol; 2021; 42(6):103088. PubMed ID: 34090018
[TBL] [Abstract][Full Text] [Related]
12. The Value of Ultrasound-Guided Fine-Needle Aspiration Cytology Combined with Puncture Feeling in the Diagnosis of Thyroid Nodules.
Li L; Chen X; Li P; Liu Y; Ma X; Ye YQ
Acta Cytol; 2021; 65(5):368-376. PubMed ID: 34350849
[TBL] [Abstract][Full Text] [Related]
13. Assessment of The Bethesda System for Reporting Thyroid Cytopathology.
Sauter JL; Lehrke H; Zhang X; Al Badri OT; Rodriguez-Gutierrez R; Delivanis DA; Singh Ospina N; Donegan D; Hamidi O; Iñiguez-Ariza N; Sharma A; Kittah NEN; Tamhane SU; Hurtado Andrade MD; Kotwal A; Jenkins SM; Spears G; Rivera M; Dean DS; Henry MR
Am J Clin Pathol; 2019 Sep; 152(4):502-511. PubMed ID: 31305880
[TBL] [Abstract][Full Text] [Related]
14. Differences in Thyroid Nodule Cytology and Malignancy Risk Between Children and Adults.
Cherella CE; Angell TE; Richman DM; Frates MC; Benson CB; Moore FD; Barletta JA; Hollowell M; Smith JR; Alexander EK; Cibas ES; Wassner AJ
Thyroid; 2019 Aug; 29(8):1097-1104. PubMed ID: 31298618
[No Abstract] [Full Text] [Related]
15. A correlative study of solitary thyroid nodules using the bethesda system for reporting thyroid cytopathology.
Arul P; Masilamani S
J Cancer Res Ther; 2015; 11(3):617-22. PubMed ID: 26458591
[TBL] [Abstract][Full Text] [Related]
16. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
Özkara SK; Bayrak BY; Turan G
Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
[TBL] [Abstract][Full Text] [Related]
17. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.
Bongiovanni M; Giovanella L; Romanelli F; Trimboli P
Thyroid; 2019 Feb; 29(2):222-228. PubMed ID: 30426887
[TBL] [Abstract][Full Text] [Related]
18. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
Tepeoğlu M; Bilezikçi B; Bayraktar SG
Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
[TBL] [Abstract][Full Text] [Related]
19. Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.
Modi L; Sun W; Shafizadeh N; Negron R; Yee-Chang M; Zhou F; Simsir A; Sheth S; Brandler TC
Cancer Cytopathol; 2020 Jul; 128(7):470-481. PubMed ID: 32078249
[TBL] [Abstract][Full Text] [Related]
20. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
